Subscribe to RoboticOncology.com RSS Feed

Chronic Prostate Inflammation May Double Cancer Risk

 
NEW YORK, NY--(Marketwired - Apr 30, 2014)  According to a new study from the Johns Hopkins Kimmel Cancer Center, men with evidence of chronic prostate inflammation may be twice as likely to develop prostate cancer as those without. Moreover, the study participants with chronic prostate inflammation were more likely to be diagnosed with high-grade, aggressive prostate cancer. 

While the observational study did not demonstrate a clear cause-and-effect relationship between prostate inflammation and cancer, the association was significant enough to warrant further investigation. David Samadi, MD, leading robotic prostate surgeon and Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, believes the connection could lead to better prostate cancer risk analysis.

"Expanding our understanding of prostate cancer risk factors, expands our opportunity for vigilance over the men most likely to be affected," said Dr. Samadi. "A deeper exploration of the inflammation link may also yield opportunities for prevention and risk mitigation."

Among the 400 study participants, 86.2 percent of overall prostate cancer cases and 88.4 percent of high-grade cases had at least one core biopsy indicating prostate tissue inflammation. Among the men without prostate cancer, prostate inflammation was detected in 78.2 percent of the cases.

The study findings were published in the Journal Cancer Epidemiology, Biomarkers & Prevention on April 18th, http://cebp.aacrjournals.org/content/early/2014/04/14/1055-9965.EPI-13-1126.abstract

Benign prostatic hyperplasia (BPH), commonly diagnosed in men over age 55, is an enlargement of the prostate gland caused by an overgrowth of cells. While BPH is not directly linked to prostate cancer, the close associations between elevated prostate-specific antigen levels (PSA), chronic prostate inflammation, and prostate cancer may now warrant closer attention.

"Prostate inflammation is highly common and men with chronic BPH need not be alarmed of cancer risk," assured Dr. Samadi. "These men have the assurance of regular screenings and attention to their prostate health. That's the biggest prostate cancer prevention strategy we have today."

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
Shlomo P. - Israel

My story starts on August 2010 when results from a PSA test showed a disturbing signal-6.3 A biopsy held in the beginning of October 2010 showed a more disturbing signal-Gleason 4+3.

more..
A. B., Romania

 “On post-op day 10, my father went to the US Tennis Open by himself and on day 12, he took a transatlantic flight home to Romania. One and two months after surgery, his PSA was 0..”

more..
W. B., USA

"I am very thankful for my success which I attribute to Dr. Samadi. My recommendation for the treatment of prostate cancer would be ROBOTIC PROSTATE SURGERY by experienced doctor such as Dr. David Samadi".

more..
Dr. K., New York, USA

Thanks God for a physician and a human being like Dr. Samadi. He literally saved my life and gave me and my family a chance to enjoy our lives together to the fullest. Dr. Samadi is a physician I would recommend without reservation and a man for whom I would do anything.

more..